Detalhe da pesquisa
1.
Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor.
Blood
; 141(11): 1308-1315, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36375118
2.
Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study.
Blood
; 141(23): 2867-2877, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36893453
3.
Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study.
Blood
; 139(15): 2338-2346, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34936697
4.
Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical features.
Blood
; 139(17): 2666-2672, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35171994
5.
HDAC6 regulates human erythroid differentiation through modulation of JAK2 signalling.
J Cell Mol Med
; 27(2): 174-188, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36578217
6.
Combining thrombopoietin receptor agonists with immunosuppressive drugs in adult patients with multirefractory immune thrombocytopenia, an update on the French experience.
Br J Haematol
; 202(4): 883-889, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37247631
7.
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study.
Blood
; 137(20): 2827-2837, 2021 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33881523
8.
Epidemiological landscape of young patients with multiple myeloma diagnosed before 40 years of age: the French experience.
Blood
; 138(25): 2686-2695, 2021 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34479366
9.
del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma.
Blood
; 137(9): 1192-1195, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33080624
10.
Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry.
Haematologica
; 108(9): 2435-2443, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36924240
11.
Heterogeneity in long-term outcomes for patients with Revised International Staging System stage II, newly diagnosed multiple myeloma.
Haematologica
; 108(5): 1374-1384, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36172814
12.
Accurate classification of plasma cell dyscrasias is achieved by combining artificial intelligence and flow cytometry.
Br J Haematol
; 196(5): 1175-1183, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34730236
13.
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations.
Br J Haematol
; 198(3): 535-544, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35438802
14.
Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study.
Blood
; 136(3): 328-338, 2020 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32321172
15.
Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study.
Hematol Oncol
; 40(5): 976-986, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35789106
16.
Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias.
Genes Chromosomes Cancer
; 60(10): 657-667, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33982372
17.
Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(10): 1378-1390, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34529931
18.
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial.
Eur J Haematol
; 107(1): 111-121, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33765335
19.
Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PML.
Eur Radiol
; 31(5): 2944-2955, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33155106
20.
Intravenous high-dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An LOC network study.
Am J Hematol
; 96(7): 823-833, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33864703